Skip to main content

Yarui Diao

Associate Professor of Cell Biology
Cell Biology

Overview


My research program, ‘Regeneration Genomics’, is dedicated to unraveling the gene regulatory mechanisms that drive cell fate changes in development and regeneration. In our quest to decode the fundamental principles of gene regulation, I have been developing several cutting-edge genomic tools, such as CREST-seq, CARGO-BioID, HiCAR, and scHiCAR that benefit both our own research and the broader scientific community.

My passion for this research was sparked during my PhD training with Dr. Zhenguo Wu in the Hong Kong University of Science and Technology (HKUST), where I explored the epigenetic mechanism underlying skeletal muscle regeneration using mice as model organisms. This experience highlighted the crucial role of epigenetic modification of non-coding gene regulatory elements, such as enhancers, in controlling stem cell fate in regeneration and cancer. To deepen my research expertise in epigenetics and genomics, I joined Dr. Bing Ren’s lab at UC San Diego (now at New York Genome Center) as a Human Frontier Science Program (HFSP) Postdoctoral Fellow. As a trainee, I published eight first-authored papers in strong journals, including PNAS, Cell Stem Cell, Dev Cell, Genome Research, Nature Methods, and Nature Genetics, on topics related to stem cell biology, regeneration, epigenetics, and genomics.

After my postdoc training, with eight faculty job offers in the US, I decided to establish my independent lab at Duke Cell Biology in September 2018. Since then, I have built a research program focused on both human pluripotent stem cells and muscle stem cells and their “niche” in regeneration, aging, and degenerative disorders, combining mechanistic studies with genomic technologies. Over the past five years, our recent discoveries include: (1) the function and regulation of non-coding cis-regulatory elements, including transposable elements, in cell fate control in both human pluripotent stem cells and muscle stem cells (Nature Genetics 2023; JCB 2023; Nature Cell Biology 2025); (2) the pathological role of muscle stem cell "niche" populations, including macrophage and FAPs, in muscular dystrophy and Peripheral Artery Disease (PAD) (Genome Medicine 2023; JVS-VS 2025; Nature Communications, revision; Cell Stem Cell, revision); (3) the development of novel 3D genome, proteomics, and single cell multi-omics tools to map chromatin architecture and protein–DNA interactions (Molecular Cell 2022, Nature Genetics 2023, Nature Biotechnolog 2026). As a PI, I have published ten senior-author papers and contributed to over 20 collaborative publications.

I am also committed to mentoring, teaching, and service. My PhD students have received research awards and progressed to postdoctoral positions in top research institutions in the US, and my former postdocs have obtained tenure-track faculty positions and established their independent labs. At Duke, I have received the Recognition of Teaching Excellence in 2023, 2024. I serve as Co-Chair of the Admissions Committee for the Cell and Molecular Biology (CMB) PhD Program. I also co-organized the 2023 Triangle Regenerative Biology Symposium and Duke’s Single Cell Colloquia (2022, 2025, 2026) to promote local scientific communications.

Complete list of my published work can be found here:
https://www.ncbi.nlm.nih.gov/myncbi/yarui.diao.1/bibliography/public/

Diao lab website: https://diaolab.github.io/

Current Duke Appointments & Affiliations


Associate Professor of Cell Biology · 2025 - Present Cell Biology, Basic Science Departments
Associate Professor in Pathology · 2025 - Present Pathology, Clinical Science Departments
Associate Professor in Orthopaedic Surgery · 2025 - Present Orthopaedic Surgery, Clinical Science Departments
Member of the Duke Cancer Institute · 2018 - Present Duke Cancer Institute, Institutes and Centers
Affiliate of the Duke Regeneration Center · 2021 - Present Duke Regeneration Center, Basic Science Departments

Recent News Items


Published June 29, 2023
Muscle Repair Research Could Mean New Therapies

View All News Items

Recent Scholarly Works


Niche-reprogramming CAR T therapy improves skeletal muscle regeneration and function in preclinical murine models of Duchenne muscular dystrophy.

Journal article Cell Stem Cell · October 29, 2026 Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disorder with no cure. Emerging dystrophin-restoring gene therapies target mutant myofibers but face challenges in efficacy and toxicities, underscoring the need for new treatments. Current therapi ... Full text Link to item Cite

Spatial chromatin architecture and accessibility co-profiling of mammalian tissues.

Journal article Nat Methods · October 2026 Cellular function depends on the spatial organization of cells and biomolecules within the tissue microenvironment. Advances in spatial omics have enabled profiling of molecular features such as transcriptome, proteome and epigenome, and there has been rap ... Full text Link to item Cite

Trimodal single-cell profiling of transcriptome, epigenome and 3D genome in complex tissues with scHiCAR.

Journal article Nat Biotechnol · February 19, 2026 The three-dimensional (3D) organization of cis-regulatory elements (CREs) is critical in transcription control. However, capturing transcriptome, epigenome and 3D genome from the same single cells remains challenging. Here we present scHiCAR (single-cell H ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2026 - 2031

Genetics and Genomics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2026 - 2031

Transposable Elements as Mechano-Response Enhancer Elements Controlling Human Genes and Cell Fate

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2026 - 2031

View All Grants

Education


University of Hong Kong (China) · 2011 Ph.D.